close
Add to watchlist
Phase Forward Inc (PFWD) Services, Business Services
Phase Forward Incorporated provides integrated enterprise-level software products, services, and hosted solutions worldwide. Its solutions are used in clinical trial and drug safety monitoring applications in the pharmaceutical, biotechnology, and medical device companies; and academic institutions, governmental regulatory agencies, contract research organizations, and other entities engaged in clinical trial and drug safety monitoring activities. The company's product lines include electronic data capture solutions consisting of InForm and LabPas; clinical data management solutions comprising Clintrial and WebSDM; drug safety solutions, including Empirica Trace, Empirica Signal, and CTSD; and interactive response technology solutions comprising Clarix. Phase Forward offers its InForm, Clarix, Empirica Signal, CTSD, and WebSDM products as a hosted application solution. Its electronic data capture and clinical data management products provide enterprise-level automation of time-consuming, and paper-based clinical trial processes, as well as offer solutions for clinical trials involving substantial numbers of clinical sites and patients; drug safety products enable customers to detect, analyze, and manage product safety throughout the product life cycle; and interactive response technologies streamline the randomization process and drug supply chain management of the customers' clinical trials. The company's products are supported by consulting and training, and application hosting and support services. Phase Forward was founded in 1997 and is headquartered in Waltham, Massachusetts.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 16.99 |
| Volume | 0 |
| Volume Avg | 572792 |
| 52 Week High | 17.09 |
| 52 Week Low | 10.29 |
| PE | 126.79 |
| PE (group average) | 40 |
| EPS Year | 0.13 |
| EPS change Q/Q | -100% |
| EPS change Q/Q Yr ago | -50% |
| EPS change Q/Q next Q est | -72.22% |
| EPS change Y/Y | 135.71% |
| REV change Q/Q | -2.72% |
| REV change Q/Q Yr ago | 17.21% |
| EPS next Q est | 0.18 |
| EPS next Y est | 0.71 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |